FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for pamidronate disodium by Mylan Institutional LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Hypercalcemia of Malignancy
• Paget Disease of Bone

Drugs mentioned

• Pamidronate disodium (Pamidronate disodium)

Snippet

SUPPL AP for PAMIDRONATE DISODIUM (PAMIDRONATE DISODIUM)